Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novartis
Novartis
Novartis Gilenya Launch: The Importance of Health Care Reform
InVivo
Wed, 10/6/10 - 10:11 am
healthcare reform
Gilenya
Novartis
MS
multiple sclerosis
Small Biotech Partnering With Big Pharma for Major Projects
Minyanville
Tue, 10/5/10 - 06:51 pm
partnerships
Human Genome Sciences
Zalbin
Novartis
Benlysta
GSK
Big Pharma behaving badly: A timeline of settlements
Fierce Pharma
Tue, 10/5/10 - 11:09 am
settlements
Novartis
Forest Labs
Allergan
Elan
JNJ
AstraZeneca
Abbott Laboratories
Eli Lilly
Merck
GSK
Pfizer
Sanofi
Novartis Discontinues Two Drugs
TheStreet.com
Tue, 10/5/10 - 07:03 am
Novartis
Human Genome Sciences
hepatitis C
antifungals
Mycograb
Here We Go Again: Novartis Fined for Off-Label Marketing
Seeking Alpha
Sun, 10/3/10 - 12:22 pm
Novartis
off label
Novartis Whistleblower Speaks: ‘We Wasted Money’
Pharmalot
Fri, 10/1/10 - 12:43 pm
Novartis
whistleblowers
off-label
Sanofi, Merck Said to Ready Sale of $1 Billion of Animal-Health Operations
Bloomberg
Fri, 10/1/10 - 10:11 am
Merck
Sanofi
animal health
M&A
Pfizer
Bayer
Boehringer Ingelheim
Eli Lilly
Novartis
Novartis to pay $422.5 million settlement
Marketwatch
Thu, 09/30/10 - 03:46 pm
Novartis
settlements
off-label
Trileptal
kickbacks
Odds Increase for Approval of Incyte's Myelofibrosis Drug
Seeking Alpha
Wed, 09/29/10 - 11:40 am
Incyte
myelofibrosis
Novartis
The most (and least) efficient Big Pharma companies
Fierce Pharma
Tue, 09/28/10 - 11:54 am
Roche
Bristol-Myers Squibb
Eli Lilly
JNJ
GSK
AstraZeneca
Novartis
Pfizer
Abbott Laboratories
Sanofi
Merck
Bayer
Better Buy: Ariad Pharmaceuticals or Corcept Therapeutics?
Motley Fool
Mon, 09/27/10 - 05:40 pm
Ariad Pharmaceuticals
Corcept Therapeutics
ridaforolimus
Merck
Cushing's disease
Corlux
Novartis
From Cicada Fungus To MS Drug: How Big Will Novartis’ New Pill Be?
Forbes
Mon, 09/27/10 - 11:59 am
Novartis
MS
multiple sclerosis
Gilenya
A Busy Week for Multiple Sclerosis News
Seeking Alpha
Sun, 09/26/10 - 12:24 pm
Novartis
Merck KGaA
Gilenya
multiple sclerosis
cladribine
Biogen Idec
Bayer
Teva Pharmaceuticals
Novartis International AG: Novartis receives EU approval recommendation for TOBI® Podhaler®, a fast and simple therapy that helps reduce treatment burden for cystic fibrosis patients
Fri, 09/24/10 - 12:19 pm
Novartis
TOBI Podhaler
cystic fibrosis
Novartis Hid Health Risks of Bone Drugs, Lawyer Tells Jury in New Jersey
Bloomberg
Fri, 09/24/10 - 11:44 am
Novartis
Zometa
Aredia
Novartis deal over, Alnylam cuts staff
Bizjournals.com
Fri, 09/24/10 - 11:16 am
Novartis
Alnylam
layoffs
RNAi
Novartis to Sell U.S. Rights to Enablex
TheStreet.com
Fri, 09/24/10 - 09:58 am
Novartis
Enablex
Warner Chilcott
overactive bladder
Gilenya: A Blockbuster in Due Time
Motley Fool
Fri, 09/24/10 - 09:55 am
Gilenya
MS
multiple sclerosis
Novartis
Novartis Cushing's Drug Passes Late-Stage Test
TheStreet.com
Wed, 09/22/10 - 09:58 am
Novartis
Cushing's disease
Novartis gains FDA approval for Gilenya drug
Marketwatch
Wed, 09/22/10 - 09:53 am
FDA
Gilenia
Novartis
Gilenya
MS
multiple sclerosis
Pages
« first
‹ previous
…
142
143
144
145
146
147
148
149
150
…
next ›
last »